MRK

Merck & Company, Inc.

125.75 USD
-0.03 (-0.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Merck & Company, Inc. stock is down -3.02% since 30 days ago. The next earnings date is Jul 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 48% of the previous 49 July’s closed higher than June. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
18 Jul 19:50 17 Jan, 2025 120.00 PUT 500 4489
19 Jul 13:43 18 Oct, 2024 130.00 CALL 100 784
19 Jul 13:51 20 Sep, 2024 120.00 CALL 35 2010
19 Jul 13:54 26 Jul, 2024 126.00 PUT 453 631
19 Jul 13:55 20 Sep, 2024 120.00 CALL 90 2010
19 Jul 15:37 17 Jan, 2025 125.00 CALL 29 3701
19 Jul 17:09 20 Sep, 2024 125.00 PUT 193 3312
19 Jul 19:09 19 Jul, 2024 120.00 CALL 51 892
19 Jul 19:10 18 Oct, 2024 120.00 CALL 51 8906
19 Jul 19:59 02 Aug, 2024 129.00 CALL 188 850

About Merck & Company, Inc.

Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.